Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Med Oncol ; 41(6): 132, 2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38687401

ABSTRACT

Lung cancer is the leading cause of death in cancer across the globe. To minimize these deaths, the replacement of traditional chemotherapy with novel strategies is significant. We have developed a nanotheranostic approach using silver nanoparticles for imaging and treatment. Silver nanoparticles (AgNPs) are fabricated by chemical reduction method. The formulation of AgNPs was confirmed by different characterization techniques like stability test, UV-Visible spectroscopy, Confocal Raman Spectroscopy, and Energy-Dispersive X-ray analysis. Further, AgNPs are coated with poly lactic-co-glycolic acid (PLGA) and then loaded with paclitaxel (Pac). Then the drug-loaded PLGA-coated AgNPs were characterized for size and zeta potential measurement by zetasizer, surface morphology study by atomic force microscopy, Fourier transform infrared spectroscopy, and release kinetics study. The imaging and anticancer properties of these nanoformulations are investigated using lung cancer cell lines. The results proved that the particles are in the nanometer range with smooth surface morphology. Moreover, the drug-loaded NPs showed a sustained release of the drug for a longer period of time. Further the formulations showed imaging property with greater anticancer efficacy. Thus, the results suggest the effective use of these nanoformulation in both lung cancer imaging and treatment using a simple and efficient approach.


Subject(s)
Lung Neoplasms , Metal Nanoparticles , Paclitaxel , Polylactic Acid-Polyglycolic Acid Copolymer , Silver , Theranostic Nanomedicine , Silver/chemistry , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Metal Nanoparticles/chemistry , Paclitaxel/administration & dosage , Paclitaxel/chemistry , Theranostic Nanomedicine/methods , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , Cell Line, Tumor , A549 Cells
2.
ACS Biomater Sci Eng ; 8(2): 444-459, 2022 02 14.
Article in English | MEDLINE | ID: mdl-35118865

ABSTRACT

The noteworthy beneficiary to date in nanotechnology is cancer management. Nanorobots are developed as the result of advancements in the nanostructure, robotics, healthcare, and computer systems. These devices at the nanoscale level are beneficial in the prevention, diagnosis, and treatment of various health conditions notably cancer. Though these structures have distinct potentialities, the usage of inorganic substances in their construction can affect their performance and can cause health issues in the body. To overcome this, naturally inspired substances are incorporated in the fabrication process of nanorobots termed biomimetic nanorobots that can overcome the immunological responses and reduce the side effects with effective functionalization. These biomimetic nanorobots can widen the opportunities in cancer imaging and therapy. Herein, an up-to-date review of biomimetic nanorobots along with their applications in cancer management is provided. Furthermore, the safety issues and future directions of biomimetic nanorobots to achieve clinical translation are also stated.


Subject(s)
Nanostructures , Neoplasms , Robotics , Biomimetics , Humans , Nanostructures/therapeutic use , Nanotechnology , Neoplasms/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...